These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 8260537

  • 1. Synergism between human recombinant monocyte chemotactic and activating factor and lipopolysaccharide for activation of antitumor properties in human blood monocytes.
    Singh RK, Fidler IJ.
    Lymphokine Cytokine Res; 1993 Oct; 12(5):285-91. PubMed ID: 8260537
    [Abstract] [Full Text] [Related]

  • 2. Synergism between human monocyte chemotactic and activating factor and bacterial products for activation of tumoricidal properties in murine macrophages.
    Singh RK, Berry K, Matsushima K, Yasumoto K, Fidler IJ.
    J Immunol; 1993 Sep 01; 151(5):2786-93. PubMed ID: 8360492
    [Abstract] [Full Text] [Related]

  • 3. Activation and priming of human monocytes by monocyte chemotactic activating factor: cooperation with other inflammatory cytokines and close association between an increase in cytoplasmic free Ca2+ and intracellular acidification.
    Azuma EK, Yuo A, Matsushima T, Kasahara T, Mizoguchi H, Saito M, Takaku F, Kitagawa S.
    Exp Hematol; 1996 Feb 01; 24(2):169-75. PubMed ID: 8641338
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor.
    Sica A, Wang JM, Colotta F, Dejana E, Mantovani A, Oppenheim JJ, Larsen CG, Zachariae CO, Matsushima K.
    J Immunol; 1990 Apr 15; 144(8):3034-8. PubMed ID: 2182712
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Human recombinant macrophage inflammatory protein-1 alpha and -beta and monocyte chemotactic and activating factor utilize common and unique receptors on human monocytes.
    Wang JM, Sherry B, Fivash MJ, Kelvin DJ, Oppenheim JJ.
    J Immunol; 1993 Apr 01; 150(7):3022-9. PubMed ID: 8454871
    [Abstract] [Full Text] [Related]

  • 11. Involvement of tumor necrosis factor in cytotoxicity mediated by human monocytes.
    Nissen-Meyer J, Hofsli E, Espevik T, Austgulen R.
    Nat Immun Cell Growth Regul; 1988 Apr 01; 7(5-6):266-79. PubMed ID: 3146697
    [Abstract] [Full Text] [Related]

  • 12. IL-1 and TNF-alpha induction of IL-8 and monocyte chemotactic and activating factor (MCAF) mRNA expression in a human astrocytoma cell line.
    Kasahara T, Mukaida N, Yamashita K, Yagisawa H, Akahoshi T, Matsushima K.
    Immunology; 1991 Sep 01; 74(1):60-7. PubMed ID: 1937574
    [Abstract] [Full Text] [Related]

  • 13. Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity.
    Ziegler-Heitbrock HW, Möller A, Linke RP, Haas JG, Rieber EP, Riethmüller G.
    Cancer Res; 1986 Nov 01; 46(11):5947-52. PubMed ID: 3756932
    [Abstract] [Full Text] [Related]

  • 14. Synergism between human recombinant gamma-interferon and muramyl dipeptide encapsulated in liposomes for activation of antitumor properties in human blood monocytes.
    Saiki I, Sone S, Fogler WE, Kleinerman ES, Lopez-Berestein G, Fidler IJ.
    Cancer Res; 1985 Dec 01; 45(12 Pt 1):6188-93. PubMed ID: 3933823
    [Abstract] [Full Text] [Related]

  • 15. Lipopolysaccharide (LPS) stimulates fresh human monocytes to lyse actinomycin D-treated WEHI-164 target cells via increased secretion of a monokine similar to tumor necrosis factor.
    Chen AR, McKinnon KP, Koren HS.
    J Immunol; 1985 Dec 01; 135(6):3978-87. PubMed ID: 3905966
    [Abstract] [Full Text] [Related]

  • 16. Activation of human peripheral-blood-derived monocytes by cis-diamminedichloroplatinum: enhanced tumoricidal activity and secretion of tumor necrosis factor-alpha.
    Gan XH, Jewett A, Bonavida B.
    Nat Immun; 1992 Dec 01; 11(3):144-55. PubMed ID: 1392402
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1).
    Yoshimura T, Matsushima K, Oppenheim JJ, Leonard EJ.
    J Immunol; 1987 Aug 01; 139(3):788-93. PubMed ID: 3298433
    [Abstract] [Full Text] [Related]

  • 19. Leukemia inhibitory factor induces interleukin-8 and monocyte chemotactic and activating factor in human monocytes: differential regulation by interferon-gamma.
    Musso T, Badolato R, Longo DL, Gusella GL, Varesio L.
    Blood; 1995 Sep 01; 86(5):1961-7. PubMed ID: 7655023
    [Abstract] [Full Text] [Related]

  • 20. Lysis of tumor cells by human blood monocytes by a mechanism independent of activation of the oxidative burst.
    Kleinerman ES, Ceccorulli LM, Bonvini E, Zicht R, Gallin JI.
    Cancer Res; 1985 May 01; 45(5):2058-64. PubMed ID: 2985242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.